| dc.contributor.author | Chen, Y | en |
| dc.contributor.author | Huang, L | en |
| dc.contributor.author | Wang, S | en |
| dc.contributor.author | Li, J-L | en |
| dc.contributor.author | Li, M | en |
| dc.contributor.author | Wu, Y | en |
| dc.contributor.author | Liu, T | en |
| dc.date.accessioned | 2021-10-05T12:29:51Z | |
| dc.date.issued | 2019-03-27 | en |
| dc.identifier.issn | 1179-1322 | en |
| dc.identifier.uri | http://hdl.handle.net/10026.1/17987 | |
| dc.format.extent | 2415 - 2424 | en |
| dc.language.iso | en | en |
| dc.publisher | Dove Medical Press | en |
| dc.title | WFDC2 contributes to epithelial-mesenchymal transition (EMT) by activating AKT signaling pathway and regulating MMP-2 expression | en |
| dc.type | Journal Article | |
| plymouth.volume | Volume 11 | en |
| plymouth.journal | Cancer Management and Research | en |
| dc.identifier.doi | 10.2147/cmar.s192950 | en |
| plymouth.organisational-group | /Plymouth | |
| plymouth.organisational-group | /Plymouth/REF 2021 Researchers by UoA | |
| plymouth.organisational-group | /Plymouth/REF 2021 Researchers by UoA/UoA01 Clinical Medicine | |
| plymouth.organisational-group | /Plymouth/REF 2021 Researchers by UoA/UoA01 Clinical Medicine/UoA01 Clinical Medicine | |
| dcterms.dateAccepted | 2019-01-31 | en |
| dc.rights.embargodate | 2021-10-06 | en |
| dc.identifier.eissn | 1179-1322 | en |
| dc.rights.embargoperiod | Not known | en |
| rioxxterms.versionofrecord | 10.2147/cmar.s192950 | en |
| rioxxterms.licenseref.uri | http://www.rioxx.net/licenses/all-rights-reserved | en |
| rioxxterms.licenseref.startdate | 2019-03-27 | en |
| rioxxterms.type | Journal Article/Review | en |
